Abstract
e14647 Background: Despite initial responsiveness, acquired resistance to both BVZ and chemotherapy in mCRC is universal. We have recently published that, chronically oxaliplatin resistant LoVo cel...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have